Roblon (One-pager): Guidance maintained after Q1 2023/24 despite weaker FOC demand
Curasight (one-pager): Halving of market implied likelihood of succes looks exaggerated
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio